NYSE

Zoetis Inc.

ZTS

3 articles

$32B Market cap · 2026-08-21

ZTS 2026-08-13

Zoetis’s U.S. companion-animal revenue fell 6% as dermatology competition drove rebates and discounts, pushing full-year net pricing to…

scuttleblurb Aug 13

ZTS · long 2026-05-08

Zoetis, the animal prescription-medicines company, is presented as a long investment despite concerns around its 2026 and 2027 outlook.

Value Investors Club May 8

Zoetis’ pet-drug blockbusters have shifted its mix from low-growth livestock medicines to durable companion-animal franchises with softer…

scuttleblurb Jun 29